ANRO
Alto Neuroscience, Inc. Common Stock (ANRO)
$28
About Alto Neuroscience, Inc. Common Stock (ANRO)
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Details
Daily high
$2.38
Daily low
$2.28
Price at open
$2.34
52 Week High
$17.55
52 Week Low
$1.60
Market cap
61.7M
Dividend yield
0.00%
Volume
88,090
Avg. volume
404,306
P/E ratio
-.97
Alto Neuroscience, Inc. Common Stock News
Details
Daily high
$2.38
Daily low
$2.28
Price at open
$2.34
52 Week High
$17.55
52 Week Low
$1.60
Market cap
61.7M
Dividend yield
0.00%
Volume
88,090
Avg. volume
404,306
P/E ratio
-.97